Compare ALV & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALV | BAX |
|---|---|---|
| Founded | 1953 | 1931 |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 10.2B |
| IPO Year | 1997 | N/A |
| Metric | ALV | BAX |
|---|---|---|
| Price | $124.47 | $21.04 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 10 |
| Target Price | ★ $133.45 | $25.00 |
| AVG Volume (30 Days) | 486.0K | ★ 8.4M |
| Earning Date | 01-30-2026 | 02-12-2026 |
| Dividend Yield | ★ 2.72% | 0.19% |
| EPS Growth | ★ 25.57 | N/A |
| EPS | ★ 9.69 | N/A |
| Revenue | $10,614,000,000.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $4.71 | $5.20 |
| Revenue Next Year | $4.08 | $2.00 |
| P/E Ratio | $12.91 | ★ N/A |
| Revenue Growth | 0.85 | ★ 3.90 |
| 52 Week Low | $75.49 | $17.40 |
| 52 Week High | $129.54 | $37.74 |
| Indicator | ALV | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 61.70 | 69.89 |
| Support Level | $121.59 | $20.08 |
| Resistance Level | $125.52 | $19.49 |
| Average True Range (ATR) | 1.87 | 0.46 |
| MACD | 0.42 | 0.21 |
| Stochastic Oscillator | 86.25 | 90.00 |
Autoliv Inc is the world-wide leader in passive safety components and systems for the auto industry. Products include seat belts, frontal air bags, side-impact air bags, air bag inflators, and steering wheels. The Renault-Nissan-Mitsubishi alliance is the company's largest customer at 10% of 2023 revenue, with Stellantis accounting for 10% and Volkswagen 9%. At 34% of 2023 revenue, the Americas was Autoliv's largest geographic region, followed by Europe at 27%, China at 20%, and rest of world at 19%.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.